13 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 13 of 13 clinical reviews.
A physician-reviewed guide for caregivers administering epitalon tetrapeptide to adolescents aged 12 to 17, covering dosing, injection technique, storage, safety monitoring, and off-label regulatory context.
What parents, coaches, and clinicians need to know before an adolescent uses Epitalon tetrapeptide, including effects on sleep, cognition, athletic performance, and academic life.
A clinically grounded guide to epitalon use in adults aged 65 and older, covering cognitive engagement, physical activity compatibility, dosing considerations, and the telomere science behind this tetrapeptide.
A clinician-reviewed guide to epitalon tetrapeptide in patients 65 and older, covering telomere biology, dosing protocols, safety monitoring, and how to transition from standard geriatric care to an epitalon regimen.
A clinician-reviewed guide for caregivers administering Epitalon to adults aged 65 and older: dosing protocols, injection technique, safety monitoring, and red-flag symptoms.
A physician-reviewed analysis of epitalon tetrapeptide use in adolescents aged 12 to 17, covering telomere biology, hormonal development, safety signals, and the near-total absence of pediatric clinical data.
A clinician-reviewed guide to Epitalon use in adolescents ages 12 to 17, covering what transition to adult care means for peptide therapy, safety considerations, dosing, and when to pause or continue.
A thorough clinical review of epitalon tetrapeptide use in adolescents aged 12 to 17, covering the absence of pediatric trial data, known pharmacology, telomere biology, pineal function, and why board-certified physicians uniformly advise against off-label use in this age group.
A clinical review of epitalon (epithalon tetrapeptide) use in pediatric populations under age 12, covering developmental biology, safety data, regulatory status, and why no evidence currently supports its use in children.
A clinical guide to epitalon use in children under 12 and the evidence-based considerations for transitioning young patients to adult care protocols, including dosing, safety data, and monitoring frameworks.
A clinician-reviewed guide for caregivers on epitalon tetrapeptide use in children under 12, covering safety evidence, dosing considerations, administration methods, and when to contact a prescriber.
What parents and clinicians need to know about epitalon tetrapeptide in children under 12, including school attendance, physical activity, and why pediatric use lacks any clinical evidence base.
A detailed clinical review of off-label epitalon use in children under 12, covering regulatory status, available evidence, safety signals, and why no prescribing pathway currently exists for this age group.